alexa
Reach Us +44-1753390542
Towards Treating Substance Abuse in Integrative Behavioral Health | OMICS International
ISSN: 2378-5756
Journal of Psychiatry
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Towards Treating Substance Abuse in Integrative Behavioral Health

Nicole M Martinez*

Doctor of Psychology, Licensed Clinical Professional Counselor, USA

*Corresponding Author:
Nicole M. Martinez
Doctor of Psychology
Licensed Clinical Professional Counselor, USA
Tel: 8479758316
E-mail: [email protected]

Received Date: July 15, 2015; Accepted Date: August 21, 2015; Published August 28, 2015

Citation: Martinez NM (2015) Towards Treating Substance Abuse in Integrative Behavioral Health. J Psychiatry 18:318 doi: 10.4172/2378-5756.1000318

Copyright: © 2015 Martinez NM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Visit for more related articles at Journal of Psychiatry

Substance abuse is an epidemic in this country. SAMSHA's 2012 survey estimates that in 2012, an estimated 23.1 million Americans (8.9% of the population) needed treatment for a problem related to drugs or alcohol, but only about 2.5 million people (1% of the population) received treatment at a specialty facility. The costs of NOT treating substance abuse are high. The most recent statistics on drugabuse.gov show that substance abuse of tobacco, alcohol, and illicit drugs is costly to our nation, exacting more than $700 billion annually in costs related to crime, lost work productivity, and healthcare.

Why aren’t people going to treatment? They have a full-time job and are the primary bread winner, rehab is expensive and insurance may not cover these services, they may be uninsured or under insured, they have family obligations, or they live with shame and fear of going to formal treatment. While residential substance abuse treatment is the gold standard, it is often not a viable option, as the numbers indicate. Intensive outpatient substance abuse services (IOP) are an excellent option, and one that can be a wonderful combination of services along with physicians and mental health clinicians. The patient can continue their daily obligations, attend IOP, see their therapist weekly, and have a doctor managing their medical needs, removing any of the obstacles that were barriers to treatment. So outpatient and primary care becomes a needed option to address these needs.

This form differs from IOP and residential treatment, in that all components are facilitated in various doctors’ offices, vs one treatment facility. The benefits to this type of treatment are that it addresses and removes all the obstacles to treatment that have been previously noted, as well as provides a more cost effective model. IOP and residential treatment can be cost prohibitive, depending on the individuals funding source, and employment situation. These forms of treatment can cost upwards of $15,000- $30,000. The shortcomings of this modality are that the ability to remove oneself from the stressors of their daily life to focus solely on treatment is a more idealized, short term, and comprehensive method. A treatment team should consist of a Primary care doctor, Psychologist, Licensed clinical social worker, or Licensed clinical professional counselor, and a Psychiatrist with an understanding of addictions. The patient should of course be attending 12 step meetings, have a sponsor, and their family and significant others should be part of the treatment process. The team should be coordinating treatment planning and practicing detailed information sharing. Diagnosis often starts at the primary care doctor’s level. During medical exams they assess the severity of health issues, do a preliminary mental health screen, blood and urine tests for substances and overall health function, as well as chronic disease, STD, and infectious disease screening if indicated. They can start treatment of any physical illness if needed. If possible, a family and significant other interview to assess the full scope of the issue can be done to further the clinical and medical picture.

Next, further diagnosis by a psychologist, psychiatrist, or substance abuse counselor should be conducted. They will be assessed based on current diagnostic criteria for substance abuse, as well as cooccurring mental health and trauma issues that accompany 70-90% of cases of substance abuse. Together this team can identify the severity of the problem, do some brief interventions, assess the patient’s motivation and readiness for change, design a treatment plan, focus on their personal strengths to tailor treatment, and connect them with community resources.

There should be a written agreement or contract, in which they agree to be referred to a higher level of care after non-compliance or a certain number of failed attempts at sobriety and this setting. There should be drug testing on a regular basis, as this is often a powerful deterrent to use. Medications should only be prescribed by the doctor on this team. Prescriptions can be for substance abuse, mental health, and ongoing health issues. A referral to detox in the beginning should be made if warranted, with the understanding that detox in and of itself is not treatment. Detox is required if it is believed the person will go into withdrawal. Withdrawal is the sick, unbearable feeling when the person cuts back and stops using drugs and alcohol abruptly. The medical team can help with medically assisted detox with a possible gradual taper, substitution drugs, and drugs to reduce cravings. Easing withdrawal symptoms, may simply mean treating symptoms of withdrawal. The type and length of withdrawal symptoms varies by substance. This allows the body to get rid of substances under supervised care, and for the individual to stop taking drug as quickly as possible, as safely as possible. Physical addiction and repeated use of drugs alters the way your brain feels pleasure, and causes physical changes to some nerve cells (neurons) in the brain. Drugs alter brains structure & functioning, and changes persist long after use is ceased. This is why the patient is at risk for relapse so long after abstinence. Medications help with different aspects of treatment, including helping the individual to stop abusing the substance, staying in treatment, learning new behavioral skills, avoiding relapse, addressing dual diagnosis, helping the brain adjust to the absence of abused substance, treating the symptoms of withdrawal, quieting drug cravings and mental agitation, and helping the patient focus on counseling. Drugs can be used to treat withdrawal and suppress withdrawal symptoms during detox. Stimulants cause fatigue, depression, and sleep problems. Barbiturates and Benzodiazepine’s can cause rebound seizures. Medications help the brain adjust to the absence of abused substances. They act slowly to quiet cravings and mental agitation. Drugs are also used for detoxification and craving management. The medications help patients disengage drug seeking and criminal behavior, and increase openness to behavioral treatment. They have the same targets in the brain as heroin and morphine. They suppress withdrawal symptoms and relieve cravings. Ativan is used for alcohol withdrawal. Naltrexone, Acamprosate and Disulfiram help with ongoing alcohol cravings. Disulfiram interferes with the degradation of alcohol, causes the accumulation of acetaldehyde which causes an unpleasant reaction to alcohol such as flushing, nausea, and palpitations, but has compliance issues.

Acamprosate decreases the symptoms of protracted withdrawal such as insomnia, anxiety, restlessness, dysphoria, depression, irritability, and is more effective with severe dependence. Naltrexone blocks opioid receptors involved in the rewarding effects of alcohol. It reduces relapse to heavy drinking, and is highly effective in some, but not all. Drugs to help with Opiate abuse are substitution drugs such as methadone, Suboxone (buprenorphine), Subutex, and naltroxene. There are numerous tobacco replacement therapies’ such as the patch, gum, spray, lozenges, buproprion, and varenicline. There is currently research underway to develop medications for stimulants, depressants, and cannabis abuse. With the medical management in place the rest of the outpatient treatment team comes into the picture in an active role. Standards of care, as outlined by NCBI include treatment that addresses the physical, psychological, social, medical and economic implications of continued use. Treatment must be appropriate to individual’s age, gender, ethnicity, and culture. No single treatment works for all substance abusers or substances, so it should be tailored to each patient. It should include a combination of treatments including: Pharmacological, psychological, psychoeducational, medical, social learning theories, support services, and non-traditional healing techniques. The frequency and intensity of treatment is dependent on the individual’s level of use, co-occurring mental health issues, concerns of harmful behaviors, and readiness to change. Longer treatment episodes are associated with better treatment outcomes. Despite what previously thought, treatment does not need to be voluntary to be effective. Sanctions from family, employers, and the criminal justice system, increase entry, retention and success. Continued use and drug seeking is compulsive, even in the face of devastating consequences. It often helps to teach the Medical/Disease Model. That like diabetes, substance abuse is chronic and relapsing. Relapse does not mean treatment has failed. It means it should be started over or adjusted, like trying various high blood pressure medications until the right fit is found. A lapse does not have to become a relapse. Substance abuse is a medical illness, not a moral failing. It is serious, but treatable. Treatment helps reduce the effects of drugs on the body and brain, and treatment helps improve physical health and everyday functioning. The individual can regain control of their life. With some training and focused treatment, therapists can help treat the substance abuse patient by engaging them in individual, group, family, couples, cognitive behavioral therapy, and dialectical behavioral therapy. Group therapy can be an essential component as the person will be challenged by peers and supported by others in treatment. 12 step, AA, NA, and CA are the most well established group treatment organizations. Individual treatment is essential for the common dual diagnosis of depression, anxiety, bipolar disorder and trauma history. Cognitive behavioral therapy (CBT) teaches the patient to recognize their moods, thoughts, feelings and situations that cause cravings. They learn to avoid triggers, replace negative thoughts and feelings with healthy ones, and skills learned in CBT can last a lifetime. The patient can gain an increased understanding of themselves and what leads to using behaviors. It can be confrontational to address denial, lies, and manipulation, as well as break down walls and accept responsibility for their behaviors. Dialectical Behavioral Therapy focuses on the emotional dysregulation associated with substance abuse. It helps to decrease self-destructive behavior and increase functioning. It increases motivation for change and coping skills. Family therapy and couples therapy should be a part of treatment if possible, as substance abuse affects the whole family, and strong relationships are essential for success. It can be a powerful force for change, and increases the likelihood of them staying in treatment. It offers the family a chance to begin to heal damage that the substance abuse has caused. Studies show, family therapy results in decreased relapse rates, increased happiness in family, and increased functioning in children of parents who abuse substances. Motivational Interviewing is another powerful tool for clinicians and physicians to utilize. It is non-confrontational, and seeks to understand and enforce a person’s natural motivation for change. These motivations become the focus of treatment so they can build a plan, make a commitment to change, create discrepancy and movement.

Relapse prevention includes developing and using coping skills to avoid relapse. The patient can identify, anticipate, avoid and cope in high risk situations. They can keep one lapse from becoming multiple relapses and feel more capable and in control. They can learn positive activities and scheduling, as well as change unhealthy habits for healthy ones. Skill building is essential to this. The patient needs to develop problem-solving skills and interpersonal skills. They work to get past denial, develop enlightenment, and work on mindfulness and distress tolerance. Mindfulness is also an important piece, as it is awareness and non-judgment of self. It is also awareness of subtle thoughts and triggers. They can catch themselves and take corrective action. If they recognize it, they don’t shame themselves and act like things are unforgivable. They can take immediate steps to not repeat past behaviors. They can learn to pay attention to internal thoughts and feelings. They can address their physical and social environments such as what they are returning home to, removing triggering items from the home, staying away from using friends and family, and learning how to fill healthy free time. In closing, I think it is clear that substance abuse is a complicated and unfortunately all too common issue in our country. Many need treatment, but few receive services. While there is no denying that formal inpatient treatment is a wonderful option for recovery, the numbers demonstrate that most of those suffering will never utilize those services due to various barriers. Standards of treatment, and a willing treatment team in Primary care and Integrated Behavioral health settings can be the setting where the individual receives lifesaving treatment and regains control of their lives.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 12090
  • [From(publication date):
    September-2015 - Nov 22, 2018]
  • Breakdown by view type
  • HTML page views : 8249
  • PDF downloads : 3841
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

streamtajm

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version